Advanced Glycation End Products and Psoriasis

Advanced Glycation End Products and Psoriasis

Advanced glycation end products (AGEs) are biologically active compounds formed physiologically throughout a sequence of chemical reactions, to generate highly oxidant-reactive aldehydes that combine covalently to proteins. They accumulate slowly in tissues during ageing but also in metabolic and se...

Full description

Bibliographic Details
Main Authors:	Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Vaccines
Subjects:	psoriasis advanced glycation end products AGEs inflammation autoimmunity
Online Access:	https://www.mdpi.com/2076-393X/11/3/617

Similar Items

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Association of advanced glycation end products in Dupuytren disease
by: Fumiaki Takase, et al.
Published: (2018-06-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Advanced glycation end products, a potential link between psoriasis and cardiovascular disease: A case–control study
by: Tulin Ergun, et al.
Published: (2019-01-01)

In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration
by: Marialena Chrysanthou, et al.
Published: (2022-01-01)

Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview
by: Pedreanez Adriana, et al.
Published: (2024-01-01)

Colorimetric and fluorometric profiling of advanced glycation end products
by: Ammanath, Gopal, et al.
Published: (2022)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
by: Jing Xu, et al.
Published: (2018-07-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Advanced Glycation End Products in Health and Disease
by: V. Prakash Reddy, et al.
Published: (2022-09-01)

Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
by: Xiaoyan Zhou, et al.
Published: (2018-02-01)

Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors
by: Wenge Zheng, et al.
Published: (2022-11-01)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
by: Elena Dozio, et al.
Published: (2023-02-01)

Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis
by: Yingjia Chen, et al.
Published: (2021-01-01)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
by: Mariyam Khalid, et al.
Published: (2022-04-01)

Association between Urinary Advanced Glycation End Products and Subclinical Inflammation in Children and Adolescents: Results from the Italian I.Family Cohort
by: Margherita Borriello, et al.
Published: (2022-10-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Advanced Glycation End Products-Induced Activation of Keratinocytes: A Mechanism Underlying Cutaneous Immune Response in Psoriasis
by: Pan Kang, et al.
Published: (2023-11-01)

Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
by: Ziling Mao, et al.
Published: (2021-12-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

The effect of protein oxidation on the formation of advanced glycation end products after chicken myofibrillar protein glycation
by: Zongshuai Zhu, et al.
Published: (2023-09-01)

Receptor Mediated Effects of Advanced Glycation End Products (AGEs) on Innate and Adaptative Immunity: Relevance for Food Allergy
by: Daniela Briceno Noriega, et al.
Published: (2022-01-01)

Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
by: Melpomeni Peppa, et al.
Published: (2021-09-01)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01)

Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study
by: Noura Mostafa Mohamed, et al.
Published: (2022-05-01)

The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
by: Sarah Louise Fishman, et al.
Published: (2018-11-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

A novel crosslinked type of advanced glycation end-product derived from lactaldehyde
by: Tomoaki Shigeta, et al.
Published: (2020-11-01)

Research progress of advanced glycation end products in glaucoma
by: Ming-Yue Han, et al.
Published: (2020-06-01)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
by: Aleksandra Twarda-Clapa, et al.
Published: (2022-04-01)

Research Trends in Advanced Glycation End Products and Obesity: Bibliometric Analysis
by: Patricia Budihartanti Liman, et al.
Published: (2022-12-01)

Research Progress in the Formation and Inhibition Mechanism of Advanced Glycation End Products
by: WU Xuan, LI Na, XU Huaide, LI Mei
Published: (2023-09-01)